Sabra Health Care REIT, Inc.(SBRA)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #193 of 2,879 stocksTOP 10%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
SBRA Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Sabra Health Care REIT, Inc. (SBRA), a Real Estate sector company. 13F Pro's AI-powered ranking engine scores SBRA at 73.5/100 on a 32-signal composite quality model, placing it at rank #193 of 2,879 stocks — the top 10% of the AI-ranked universe. SBRA scores in the top quartile across free cash flow (96.3), earnings quality (95.8), profitability (95.0). Areas of concern include revenue scale (32.4), which score below median versus the broader universe. Shareholder dilution risk is elevated at 47.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Sabra Health Care REIT, Inc. reports quarterly revenue of $221.8M, net income of $40.9M, an operating margin of 17.8%. Top institutional holders of SBRA by reported 13-F value include BlackRock,, PRINCIPAL FINANCIAL GROUP, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. SBRA trades on the Nasdaq exchange and files with the SEC under CIK 1492298. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SBRA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Sabra Health Care REIT, Inc. directly from SEC EDGAR. Sabra Health Care REIT, Inc.'s 13F Pro composite quality score has ranged between 8 and 85 since 2021, currently 73.5 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.
What's Driving SBRA's Business? Latest 10-Q Breakdown
AI-extracted from Sabra Health Care REIT, Inc.'s 10-Q filed 2026-04-29 — Q1 2026 (quarter ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Sabra reported Q1 2026 net income of $40.9M with total revenues of $221.8M, driven by resident fees and services growing 51% YoY to $116.7M from new Senior Housing-Managed acquisitions.
Biggest Revenue Drivers
14 Senior Housing-Managed communities acquired after January 1, 2025, and seven facilities transitioned to Senior Housing-Managed portfolio contributed $26.1M and $10.0M increases, respectively.
Decrease due to transition of facilities to Senior Housing-Managed and dispositions, partially offset by lease amendments and annual CPI-based rental increases.
Income earned on loans receivable and preferred returns on preferred equity investments; decreased slightly from investment repayments.
Largest Expense Items
Increase driven by 14 newly acquired Senior Housing-Managed communities ($16.9M), seven transitioned facilities ($7.0M), and higher labor costs and staffing.
Increase from properties acquired after January 1, 2025, and 2025 acquisition of operations of four Senior Housing-Managed communities previously leased.
Increase primarily related to higher interest expense on Credit Agreement borrowings as rates rose.
Increase due to higher team member compensation from increased staffing and annual salary adjustments, plus hosting 2026 Operator Conference.
Margins: Operating margin pressured as senior housing managed operating expenses grew 45% YoY, offsetting 51% revenue growth from resident fees. Operating cash flow remained solid at $98.4M for Q1, supporting dividend payments of $75.7M.
Watch Items from the Filing
- Three skilled nursing/transitional care facilities with net book value of $33.2M classified as held for sale as of March 31, 2026; sold post-quarter for $79.4M aggregate gross sales price.
- Senior Housing-Managed portfolio represented significant operating expense concentration at $81.9M in Q1 2026 (+45% YoY); dependent on labor costs, occupancy levels, and rate growth.
- Medicare rates for skilled nursing facilities (31.2% of Q1 revenues) increased 3.2% for FY2026, with proposed 2.4% increase for FY2027 per April 2026 CMS rule.
- Company maintains $1.2B liquidity comprising $116.5M cash, $645.0M available under revolving credit facility, and $451.0M from forward equity sale agreements; Revolving Credit Facility matures January 4, 2027 with two six-month extension options.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Revenue
Q1 2026
$221.8M
Net Income
Q1 2026
$40.9M
Free Cash Flow
Q1 2026
$98.4M
Operating Margin
Q1 2026
17.8%
ROIC
Q1 2026
0.7%
D/E Ratio
Q1 2026
0.96
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+10.2% YoYNet Income
+22.8% YoYEPS (Diluted)
+18.5% YoYTotal Assets
+3.6% YoYTotal Debt
+4.6% YoYOp. Cash Flow
+12.3% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $774.6M +10.2% | $703.2M +8.6% | $647.5M +3.6% | $624.8M +4.4% | $598.6M -9.5% | $661.7M |
| Net Income | $155.6M +22.8% | $126.7M +821.1% | $13.8M +117.7% | $-77.6M -156.1% | $138.4M +100.6% | $69.0M |
| EPS (Diluted) | $0.64 +18.5% | $0.54 +800.0% | $0.06 +117.6% | $-0.34 -150.7% | $0.67 +81.1% | $0.37 |
| Total Assets | $5.49B +3.6% | $5.30B -1.5% | $5.39B -6.3% | $5.75B -4.0% | $5.99B -1.4% | $6.07B |
| Total Debt | $2.53B +4.6% | $2.42B +0.1% | $2.41B -3.7% | $2.51B +5.7% | $2.37B -1.2% | $2.40B |
| Operating Cash Flow | $348.6M +12.3% | $310.5M +3.3% | $300.6M -4.8% | $315.7M -11.0% | $354.9M -4.7% | $372.5M |
AI Insight: SBRA Financial Trends
Revenue surged 26% from $176M in Q2 2024 to $222M in Q1 2026, but rising debt to $2,665M and volatile net income cloud the growth story.
• Revenue grew steadily from $176M in Q2 2024 to $222M in Q1 2026, a 26% increase over seven quarters.
• Net income is highly volatile — peaking at $66M in Q2 2025 before falling to $23M in Q3 2025 and $27M in Q4 2025.
• Operating cash flow improved from $80M in Q2 2024 to $98M in Q1 2026, with consistent $80M+ floors across most quarters.
• Total debt rose from $2,447M in Q2 2024 to $2,665M in Q1 2026, while equity grew modestly from $2,762M to $2,786M.
⚠ Total debt jumped $136M in Q1 2026 alone to $2,665M — the highest level in the observed period.
⚠ Net income swings of $40M+ between quarters suggest lumpy asset gains/losses; underlying earnings quality warrants scrutiny.
⚠ Operating income data is absent across all periods, limiting visibility into core property-level profitability trends.
AI Insight: SBRA Ratio Trends
SBRA's profitability surged in Q2 2025 then sharply reversed, with Q4 2025–Q1 2026 margins back near cycle lows and leverage ticking up to 0.96 D/E.
• Operating margin swung from 34.5% in Q2 2025 to 11.4% in Q3 2025 and 12.3% in Q4 2025 — a dramatic intra-year collapse.
• ROIC peaked at 5.0% in Q2 2025 but fell to 1.6% in Q3 2025 and sits at 2.9% in Q1 2026, well below the peak.
• D/E ratio has crept from 0.88 in Q4 2024 to 0.96 in Q1 2026, the highest level in the observed period.
• TTM operating margin of 18.7% and ROE of 5.6% reflect modest recovery when smoothing through the volatile quarterly swings.
⚠ D/E reached 0.96 in Q1 2026 — highest in the dataset — while ROIC remains subdued at 2.9%; leverage rising faster than returns is concerning.
⚠ Q2 2025's 34.5% operating margin appears to be a one-off spike; sustainability of any margin recovery toward that level warrants close monitoring.
⚠ Q1 2026 margin of 17.8% is recovering from Q3–Q4 2025 lows; whether this improvement continues into Q2 2026 is a key inflection point.
Get alerted when SBRA's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Sabra Health Care REIT, Inc. including:
Top Institutional Holders of SBRA
BlackRock, Inc.
$751.9M39,098,389 shPRINCIPAL FINANCIAL GROUP INC
$481.8M25,052,121 shVANGUARD PORTFOLIO MANAGEMENT LLC
$445.0M23,143,248 shSTATE STREET CORP
$232.7M12,099,951 shVANGUARD CAPITAL MANAGEMENT LLC
$216.0M11,230,748 shGEODE CAPITAL MANAGEMENT, LLC
$143.3M7,450,769 shNuveen, LLC
$128.3M6,673,284 shBANK OF AMERICA CORP /DE/
$104.0M5,409,161 shCHARLES SCHWAB INVESTMENT MANAGEMENT INC
$91.8M4,773,303 shCENTERSQUARE INVESTMENT MANAGEMENT LLC
$74.6M3,877,810 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $751.9M | 39,098,389 |
| PRINCIPAL FINANCIAL GROUP INC | $481.8M | 25,052,121 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $445.0M | 23,143,248 |
| STATE STREET CORP | $232.7M | 12,099,951 |
| VANGUARD CAPITAL MANAGEMENT LLC | $216.0M | 11,230,748 |
| GEODE CAPITAL MANAGEMENT, LLC | $143.3M | 7,450,769 |
| Nuveen, LLC | $128.3M | 6,673,284 |
| BANK OF AMERICA CORP /DE/ | $104.0M | 5,409,161 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $91.8M | 4,773,303 |
| CENTERSQUARE INVESTMENT MANAGEMENT LLC | $74.6M | 3,877,810 |
More Real Estate Companies
View all Real Estate →Put SBRA on your watchlist
Track score changes the day Sabra Health Care REIT, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is SBRA a good stock to buy?
13F Pro's AI-powered analysis of Sabra Health Care REIT, Inc. (SBRA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Real Estate sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SBRA are available on the SBRA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own SBRA?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SBRA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Sabra Health Care REIT, Inc.'s investment landscape.